Medico: NEET-PG | INICET Prep vs ADRPLEXUS INFINITY使用状況と統計

The key to cracking any competitive exam is covering the entire syllabus via the Previous year's Questions & Topics (PYQ & PYT). Medico's 15000+ practice questions cover the entire syllabus from fundamentals to clinical questions using the last ten years' NEET-PG & INI-CET Exam pattern. Medico's learning strategy's unique feature is solving MCQs and deeply understanding the topic via discussions with excellent faculty and mentors.
  • Apple App ストア
  • 無料
  • 教育

ストアランキング

- -

ADRPLEXUS INFINITY App is a digital resource for doctors, by the technical wing of AdrPlexus. Our app is one of its kind and acts as one-stop place for aspirants to go for e-Learning. Curated content with the highest effort-yield ratio together with a conceptual and time-bound approach makes ADrPlexus app a very effective learning tool for NeXT and INI-CET Major Features includes Daily Questions, Courses packed with targeted learning Videos, QBank, ToDo, Live Sessions The app also provides options to choose other institutional courses with more detailed course contents. All contents in are created and curated by experts to provide the maximum knowledge to aspirants in the shortest time possible. For support and suggestions, please contact us at support@adrplexus.com ---------- ***The information on this APP is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this APP is for general information purposes only.
  • Apple App ストア
  • 無料
  • 教育

ストアランキング

- -

Medico: NEET-PG | INICET Prep対ADRPLEXUS INFINITYランキング比較

と過去28日間の Medico: NEET-PG | INICET Prep ランキング傾向を比較 ADRPLEXUS INFINITY

ランキング

ご利用可能なデータがありません

Medico: NEET-PG | INICET Prep 対 ADRPLEXUS INFINITY 国の比較によるランキング

と過去28日間の Medico: NEET-PG | INICET Prep ランキング傾向を比較 ADRPLEXUS INFINITY

表示できるデータはありません

無料トライアルで任意のサイトと比較する

始める
Medico: NEET-PG | INICET Prep VS.
ADRPLEXUS INFINITY

12月 14, 2024